Q1 EPS Estimates for Henry Schein Reduced by Analyst
Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...
KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...
Barrington Research Issues Positive Forecast for Henry Schein (NASDAQ:HSIC) Stock Price
Henry Schein (NASDAQ:HSIC – Free Report) had its price objective hoisted by Barrington Research from $82.00 to $90.00 in a research note published on Thursday,Benzinga reports. They currently have an ...
Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Henry Schein Inc. stock outperforms competitors on strong trading day
Shares of Henry Schein Inc. advanced 4.95% to $79.87 Wednesday, on what proved to be an all-around poor trading session for ...
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Business Wire4d
Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
Henry Schein announces strategic investment by KKR, board changes, and provides preliminary unaudited financial results and ...
KKR builds stake in Henry Schein, agrees deal for board seats, WSJ reports
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
Henry Schein price target raised to $78 from $75 at Mizuho
Mizuho analyst Steven Valiquette raised the firm’s price target on Henry Schein (HSIC) to $78 from $75 and keeps a Neutral rating on the ...